Common medication that can reduce the risk of strokes

Researchers have identified very commonly prescribed medication, which can reduce the risk of vascular expansion of “infusion”, a kind of life -threatening stroke, which occurs due to bleeding in the environment around the brain. The study, which spans two decades and participated in nearly 44,000 people, provides a new hope for preventing this serious situation and has been published in the journal Neurology; The Medical Journal of the American Academy of Neuroscience. The study provides proof of third degree, which indicates a large connection between some of the prescribed medication and the subsequent development of strokes, although these results are not yet final, but it provides a promising tendency for future investigations and clinical experiences, and the results do not prove that this medicine does not reduce the causal risk of this type of vascular expansion; But it just shows the link. The analysis revealed that some medications, including some blood pressure treatments, known as lazinopril and aldodibin, as well as medicine to reduce harmful cholesterol levels, such as symbastatin, diabetes “metformin” and the medicine of tamsulosin intended for the treatment of prostate enlargement, associated with a reduction in the risk of strips. It is not recommended to take any kind of this medicine to reduce the risk of strokes or for any other medical purposes, except after consulting a doctor. “We urgently need new ways to prevent this kind of stroke, which occurs at a younger age and with a higher mortality rate than other strokes,” says the prevention of stroke, study author, Jose Peter Canning, a researcher at Utrecht University Medical Center in the Netherlands. ‘Canning’ notes that the current surgical treatments for the blood vessels in the brain pose the risk of permanent disability and death that often exceed the potential benefits, so the prevention of blood vessels will prevent, and it will be very useful to use a surgical agent. The researchers looked at 4,879 people torn in the stretch of the blood vessels in the brain, called unbelieving bleeding, and these people were compared to others of the same age and gender, or a total of 4.911 people who did not have a tear blood vessels in the brain, and then checked the electronic health records to find out what people were taking. After adjusting the other factors that can affect the risk of stroke, such as high blood pressure, smoking, alcohol use and the total number of other health conditions, the researchers found that people who now take Lisenopril were less likely to have a 37%break from blood vessels in the brain, compared to people who do not use the drug. People who took Simvstatin were also 22%less likely to develop stroke compared to those who did not take the drug, and people who took metformin were 42%less likely to develop stroke, and those who took tamsulosin were 45%less likely. The researchers also found an increase in the risk of rift of blood vessels in the brain in people taking four medicines; It is a “warfarin” that is diluted for blood; The antidepressant “Venlafaxin”, the “Brooklyorbrezine” antipsychotic, and the “Limpamol” pain reliever, and the authors of the study confirm that these results should lead to more research on the preventative effects of these drugs. This research is an important step forward in trying to prevent bleeding in transgressions, which remains a major cause of disability and death related to stroke, and by identifying existing medications that can reduce the risk of this condition, the study opens new treatment methods, which can benefit millions of patients around the world.